Thackray Helen M.

Thackray Helen M. is listed in filings as Chief R&D Officer at BioCryst Pharmaceuticals Inc. This profile follows SEC Form 4 activity through Apr 2, 2025, including 5 public disclosures. Recent filings connect the profile to BioCryst Pharmaceuticals Inc (BCRX). The current snapshot covers public activity from Dec 17, 2024 to Apr 2, 2025. Reported amounts are shown as $56.4K to $45.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.